Doctors test if weight loss surgery changes how blood thinners work

NCT ID NCT04180436

Summary

This study aimed to understand how weight loss surgery and severe obesity affect how the body processes a common blood thinner called rivaroxaban. Researchers gave the medication to 67 people across four groups: severely obese individuals, those who had gastric bypass surgery, those who had sleeve gastrectomy surgery, and a control group. They measured drug levels in the blood over time to see if surgery or body weight changed how the medication was absorbed and worked.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MORBID OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CHRU de Brest

    Brest, France, 29609, France

Conditions

Explore the condition pages connected to this study.